Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heejoon Jang

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Alimentary Pharmacology & Therapeutics|May 30, 2023
Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLDYun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, et al.
Clinical and Molecular Hepatology|July 15, 2025
Erratum to 'Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study' [Clin Mol Hepatol 2024;30:487-499]Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, et al.
Clinical and Molecular Hepatology|May 7, 2024
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort studySeogsong Jeong, Yun Hwan Oh, Joseph C Ahn, et al.
Journal of Hepatocellular Carcinoma|December 15, 2021
Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched StudyMinseok Albert Kim, Heejoon Jang, Na Ryung Choi, et al.
Clinical and Molecular Hepatology|May 29, 2020
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatmentCheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, et al.
Canadian Journal of Gastroenterology & Hepatology|September 24, 2024
The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South KoreaSung Won Chung, Min Kyung Park, Xiao Zhang, et al.
Gastroenterology|January 31, 2026
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease SubtypesGi-Ae Kim, Heejoon Jang, Moon Young Kim, et al.
Clinical and Molecular Hepatology|May 10, 2024
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort studyMoon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, et al.
Journal of Hepatocellular Carcinoma|June 24, 2021
Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisSung Won Chung, Min Kyung Park, Young Youn Cho, et al.
Eclinicalmedicine|June 17, 2024
Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort studyWon Sohn, Soo Young Park, Tae Hee Lee, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|May 30, 2023
Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLDYun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, et al.
Clinical and Molecular Hepatology|July 15, 2025
Erratum to 'Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study' [Clin Mol Hepatol 2024;30:487-499]Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, et al.
Clinical and Molecular Hepatology|May 7, 2024
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort studySeogsong Jeong, Yun Hwan Oh, Joseph C Ahn, et al.
Journal of Hepatocellular Carcinoma|December 15, 2021
Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched StudyMinseok Albert Kim, Heejoon Jang, Na Ryung Choi, et al.
Clinical and Molecular Hepatology|May 29, 2020
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatmentCheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, et al.
Canadian Journal of Gastroenterology & Hepatology|September 24, 2024
The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South KoreaSung Won Chung, Min Kyung Park, Xiao Zhang, et al.
Gastroenterology|January 31, 2026
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease SubtypesGi-Ae Kim, Heejoon Jang, Moon Young Kim, et al.
Clinical and Molecular Hepatology|May 10, 2024
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort studyMoon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, et al.
Journal of Hepatocellular Carcinoma|June 24, 2021
Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisSung Won Chung, Min Kyung Park, Young Youn Cho, et al.
Eclinicalmedicine|June 17, 2024
Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort studyWon Sohn, Soo Young Park, Tae Hee Lee, et al.
Pageof 4